Siren »

Kailera Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Siren from 13F filings

Historical chart of Siren investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2026-06-30 $49M 2.2M 22.03

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Veradermics Common Stock (MANE)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Rhythm Pharmaceuticals (RYTM)
Lexicon Pharmaceuticals Com New (LXRX)
Enliven Therapeutics (ELVN)
Spyre Therapeutics Com New (SYRE)
Parabilis Medicines

View all positions for Siren

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics